In a phase II trial, adults with a BMI of 30 or 27 kg/m with comorbidities were randomized to receive efpeglenatide at doses of 4 mg weekly, 6 mg weekly, 6 mg biweekly, or 8 mg biweekly, or a placebo, all combined with a hypocaloric diet [17]
It was well known to us that modified fasting therapy was an effective approach for weight management, however, persistence hunger and fatigue during the fasting period affected compliance with modified fasting therapy
Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression
The following sections summarize the recent findings of these studies
Limitations of conventional therapies Modern pharmacological strategies for GI disorders rely on drugs such as antacids, proton pump inhibitors (PPIs), H 2 receptor antagonists, anti-inflammatory agents, antibiotics, and laxatives